ID24861A - THE PROCESS TO MAKE THE STREET OF THE GROWTH HORMONE SECRETION - Google Patents

THE PROCESS TO MAKE THE STREET OF THE GROWTH HORMONE SECRETION

Info

Publication number
ID24861A
ID24861A IDP20000134D ID20000134D ID24861A ID 24861 A ID24861 A ID 24861A ID P20000134 D IDP20000134 D ID P20000134D ID 20000134 D ID20000134 D ID 20000134D ID 24861 A ID24861 A ID 24861A
Authority
ID
Indonesia
Prior art keywords
street
make
growth hormone
hormone secretion
secretion
Prior art date
Application number
IDP20000134D
Other languages
Indonesian (id)
Inventor
Frank Robert Busch
Charles Kwok-Fung Chiu
Clifford Nathaniel Meltz
Ronald James Post
Peter Robert Rose
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ID24861A publication Critical patent/ID24861A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
IDP20000134D 1999-02-26 2000-02-24 THE PROCESS TO MAKE THE STREET OF THE GROWTH HORMONE SECRETION ID24861A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12274599P 1999-02-26 1999-02-26

Publications (1)

Publication Number Publication Date
ID24861A true ID24861A (en) 2000-08-31

Family

ID=22404505

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP20000134D ID24861A (en) 1999-02-26 2000-02-24 THE PROCESS TO MAKE THE STREET OF THE GROWTH HORMONE SECRETION

Country Status (44)

Country Link
US (2) US6541634B2 (en)
EP (2) EP1031575B1 (en)
JP (3) JP3437813B2 (en)
KR (2) KR100372063B1 (en)
CN (3) CN1515570A (en)
AP (1) AP1221A (en)
AR (2) AR029617A1 (en)
AT (1) ATE277944T1 (en)
AU (1) AU764122B2 (en)
BG (1) BG104175A (en)
BR (2) BRPI0000967B8 (en)
CA (1) CA2299495C (en)
CO (1) CO5160252A1 (en)
DE (1) DE60014212T2 (en)
DK (1) DK1031575T3 (en)
DZ (1) DZ3018A1 (en)
EA (1) EA003218B1 (en)
EE (1) EE200000193A (en)
ES (1) ES2226712T3 (en)
GT (1) GT200000018A (en)
HK (1) HK1030219A1 (en)
HN (1) HN2000000021A (en)
HR (1) HRP20000103A2 (en)
HU (1) HUP0000907A3 (en)
ID (1) ID24861A (en)
IL (2) IL157103A (en)
IN (1) IN192352B (en)
IS (1) IS5380A (en)
MA (1) MA25072A1 (en)
NO (1) NO20000965L (en)
NZ (1) NZ503062A (en)
OA (1) OA11325A (en)
PA (1) PA8491201A1 (en)
PE (1) PE20001550A1 (en)
PL (1) PL338628A1 (en)
PT (1) PT1031575E (en)
SG (1) SG90096A1 (en)
SI (1) SI1031575T1 (en)
SK (1) SK284982B6 (en)
TN (1) TNSN00035A1 (en)
TR (1) TR200000536A2 (en)
TW (2) TW200718702A (en)
UA (1) UA70306C2 (en)
ZA (1) ZA200000888B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1132388A3 (en) * 2000-03-09 2004-03-03 Pfizer Products Inc. Hexahydropyrazolo[4,3-c]pyridine metabolites
AU2001264977B2 (en) 2000-05-30 2005-04-14 Merck & Co., Inc. Melanocortin receptor agonists
AU2003237595A1 (en) * 2003-05-26 2004-12-13 Biocon Limited Process for the preparation of s(+)-2-ethoxy-4-(n-{1-(2-piperidinophelyl)-3-methyl-1- butyl} aminocarbonylmethyl)benzoic acid derivatives
WO2005027913A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue
US9117477B2 (en) 2013-05-08 2015-08-25 HGST Netherlands B.V. Perpendicular magnetic recording media having novel seed layer
TWI629982B (en) 2013-05-28 2018-07-21 拉夸里亞創藥股份有限公司 Polymorph forms
CN109320515A (en) * 2018-11-22 2019-02-12 常州大学 A kind of method of asymmetric synthesis of Capromorelin chiral intermediate

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610980D0 (en) 1986-05-06 1986-06-11 Ici America Inc Heterocyclic fused tricyclic compounds
GB8901423D0 (en) 1989-01-23 1989-03-15 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof
US5536716A (en) 1992-12-11 1996-07-16 Merck & Co., Inc. Spiro piperidines and homologs which promote release of growth hormone
AU1172995A (en) 1993-11-09 1995-05-29 Merck & Co., Inc. Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
US5609150A (en) 1995-04-18 1997-03-11 Maged; Jeffrey M. Method for dilating respiratory passages
TW432073B (en) 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
AU2334097A (en) 1996-03-21 1997-10-10 Merck & Co., Inc. 4-spiroindoline piperidines promote release of growth hormone
WO1997036873A1 (en) 1996-04-03 1997-10-09 Merck & Co., Inc. Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
UA64751C2 (en) * 1997-06-25 2004-03-15 Пфайзер Продактс Інк. Treatment of insulin tolerance using substances increasing growth hormone secretion
UA53716C2 (en) 1997-06-25 2003-02-17 Пфайзер Продактс Інк. A substituted dipeptide tartaric salt as an agent stimulating the growth hormone secretion
JP3514774B2 (en) 1997-06-25 2004-03-31 ファイザー・インク Dipeptide derivatives as growth hormone secretagogues

Also Published As

Publication number Publication date
AU1947100A (en) 2000-08-31
HUP0000907A3 (en) 2001-05-28
EA003218B1 (en) 2003-02-27
HUP0000907A2 (en) 2001-03-28
HN2000000021A (en) 2001-02-02
JP2003261565A (en) 2003-09-19
PT1031575E (en) 2004-11-30
CN1515570A (en) 2004-07-28
BRPI0000967B8 (en) 2021-12-07
IL134599A (en) 2006-12-10
DK1031575T3 (en) 2005-01-03
HRP20000103A2 (en) 2001-04-30
NO20000965D0 (en) 2000-02-25
TW200718702A (en) 2007-05-16
ATE277944T1 (en) 2004-10-15
AR029617A1 (en) 2003-07-10
GT200000018A (en) 2001-08-16
IL157103A (en) 2007-07-24
EA200000172A2 (en) 2000-08-28
DE60014212T2 (en) 2005-12-15
EP1449842A1 (en) 2004-08-25
SK284982B6 (en) 2006-03-02
OA11325A (en) 2003-10-27
BRPI0017522B1 (en) 2013-09-24
PL338628A1 (en) 2000-08-28
JP3437813B2 (en) 2003-08-18
BRPI0000967B1 (en) 2012-06-12
PA8491201A1 (en) 2001-04-30
US20020002283A1 (en) 2002-01-03
CN1837205A (en) 2006-09-27
KR100361783B1 (en) 2002-11-22
AP2000001754A0 (en) 2000-03-31
BRPI0017522B8 (en) 2021-05-25
CA2299495C (en) 2010-06-15
US20030158414A1 (en) 2003-08-21
US6673929B2 (en) 2004-01-06
EA200000172A3 (en) 2000-10-30
EE200000193A (en) 2000-10-16
EP1031575B1 (en) 2004-09-29
EP1031575A1 (en) 2000-08-30
TWI286142B (en) 2007-09-01
BRPI0017522A2 (en) 2009-12-22
AU764122B2 (en) 2003-08-07
CN1137891C (en) 2004-02-11
CA2299495A1 (en) 2000-08-26
ES2226712T3 (en) 2005-04-01
BG104175A (en) 2000-12-29
KR100372063B1 (en) 2003-02-14
NZ503062A (en) 2001-07-27
AR053722A2 (en) 2007-05-16
CO5160252A1 (en) 2002-05-30
AP1221A (en) 2003-11-03
KR20020065455A (en) 2002-08-13
HU0000907D0 (en) 2000-04-28
MA25072A1 (en) 2000-10-01
SI1031575T1 (en) 2005-02-28
UA70306C2 (en) 2004-10-15
TR200000536A2 (en) 2000-09-21
CN1270960A (en) 2000-10-25
JP4051314B2 (en) 2008-02-20
DE60014212D1 (en) 2004-11-04
IN192352B (en) 2004-04-10
ZA200000888B (en) 2001-08-23
JP2000247974A (en) 2000-09-12
JP2003327585A (en) 2003-11-19
US6541634B2 (en) 2003-04-01
SG90096A1 (en) 2002-07-23
KR20010006698A (en) 2001-01-26
PE20001550A1 (en) 2001-01-11
NO20000965L (en) 2000-08-28
HK1030219A1 (en) 2001-04-27
IS5380A (en) 2000-08-27
BRPI0000967A (en) 2001-09-11
IL134599A0 (en) 2001-04-30
SK2302000A3 (en) 2000-11-07
DZ3018A1 (en) 2004-03-20
TNSN00035A1 (en) 2005-11-10
IL157103A0 (en) 2004-02-08

Similar Documents

Publication Publication Date Title
ATE310728T1 (en) TETRAHYDROISOCHINOLINE ANALOGUE AS GROWTH HORMONE SECRETAGOGEN
GB2349273B (en) Method of making photovoltaic device
EE201300037A (en) Antibodies to insulin-like growth factor I receptor
ID27013A (en) THE PROCESS TO MAKE A PIECE OF POWDER FOR MAKING GLASS
PL356297A1 (en) Recombinant antibodies to human interkleukin-1 beta
ATE362472T1 (en) GROWTH HORMONE SECRETION PROMOTERS
ID26441A (en) PROCESS TO PRODUCE ANHYDRIDAL FTALATES
NO20000823L (en) A means to promote secretion of growth hormone
PT1150966E (en) METHOD OF PREPARATION OF 5-CYANOFOHALIDE
AR025582A1 (en) SIMILAR POLYPEPTIDES TO THE FIBROBLASTO GROWTH FACTOR
ID24861A (en) THE PROCESS TO MAKE THE STREET OF THE GROWTH HORMONE SECRETION
HUP0202519A3 (en) Production of proteins
TW419029U (en) Structure improvement of sliding-sleeve tyep waterproof night lamp
DE60039965D1 (en) COMPOSITION FOR THE ACQUISITION OF IMMUNOLOGICAL TOLERANCE
DE69927048D1 (en) IBANDROINIC ACID TO PROMOTE OSSEOINTEGRATION OF ENDOPROTHESIS
PT1228056E (en) METHOD OF PREPARING CITALOPRAME
EE200200253A (en) Method for the preparation of conjugated linolenic acid
ATE278712T1 (en) ANTIBODIES TO PLACENTAL PROTEIN 13
NO20021234D0 (en) Use of thienopyrimidines
TW394354U (en) Betterment for structure of night lamp
FR2802802B1 (en) SPLIT FOR LOWER LIMBS OF THE POSTERIOR GUTTER TYPE
GB2356297B (en) Improvements to street lighting
NO20022671D0 (en) Process for the preparation of thienopyrimidines
EE200200053A (en) Process of preparation of isoretinoin
FI20002577A0 (en) Method to take off